RXRX (Recursion) Total Aset Perusahaan

Recursion Pharmaceuticals (RXRX) is transforming drug discovery by leveraging neural networks to rapidly identify biological targets. Total assets on this chart confirm a growing base, where the 1257.59 metric serves as the target level. AI automation in genetics and oncology minimizes pipeline risks, while the alliance with NVIDIA and powerful supercomputers provide the company with a significant technological moat.

RXRX: Aset Agregat Perusahaan Recursion Pharma 04.07.2022 - 27.10.2026

Rincian metrik komprehensif lan analitis Recursion (RXRX)

- rega lan prakiraan konsensus rega:

Kurs saham Recursion Pharmaceuticals|RXRX - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Recursion Corp|RXRX - Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Saham Recursion|RXRX - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku recursion.com|RXRX - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Modal Recursion Pharmaceuticals|RXRX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Recursion Pharmaceuticals, Inc.|RXRX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Recursion Corp

Pambiji fundamental:Recursion Pharma, RXRX

Produk asil prodhuksi Recursion Pharmaceuticals Inc

For Recursion Pharmaceuticals (RXRX), which integrates robotic laboratories and AI, total assets represent the aggregate resource base necessary to scale breakthrough biomedical research. The current calculation of total assets at 1257.59 was derived reverse-engineered via ROA, allowing investors to assess the actual volume of assets and liabilities to determine the financial stability of this innovative development model.

Pesaing Recursion Pharmaceuticals (RXRX)